Advertisement
Home 2016

Archives

Urinary tract infections are common in nursing home residents

UTI Prevention Strategies Lacking in Nursing Homes

0
UTIs more often linked to causes other than catheter use; many facilities lack preventive measures
Three-quarters of emergency department patients who received antibiotics to treat suspected sexually transmitted infections tested negative for the infections

ERs May Be Overprescribing Antibiotics for Possible STIs

0
Three in four tests for gonorrhea, chlamydia came back negative
Women in the United States with atrial fibrillation are more likely than men with the condition to suffer a stroke

Women With A-Fib Receive Less Heart Care, Suffer More Strokes

0
Study reflects gender differences in treatment of atrial fibrillation
A new smartphone app may help lung cancer patients live longer and better by monitoring their symptoms and alerting doctors to potential problems

ASCO: Smartphone App May Help Lung Cancer Patients Live Longer

0
Researchers found tracking symptoms, alerting doctors to problems early led to longer survival
Black breast cancer survivors in the United States are less likely than white or Hispanic women to get follow-up genetic screening and surgeries that can help prevent cancer recurrence

ASCO: Follow-Up Care Lacking for Black Women With Breast Cancer

0
Genetic testing, risk-reducing surgery more likely for whites, Hispanics
Daratumumab (Darzalex)

ASCO: Adding Daratumumab Early in Myeloma Treatment Efficacious

0
Response rate doubled for patients with relapsed or refractory multiple myeloma
Three-quarters of young or middle-aged Americans with terminal cancer receive aggressive treatment during the last month of their lives

ASCO: Aggressive Treatment Common in Terminal CA Patients

0
Three in four of young or middle-aged patients get aggressive therapies in last months of lives
Young children with high-risk neuroblastoma have improved survival when they receive two autologous stem-cell transplants rather than one

ASCO: Double ASCT Beneficial in High-Risk Neuroblastoma

0
Tandem treatments might give survival edge to children with neuroblastoma
Patients with advanced bladder cancer may benefit from the anti-PD-L1 immunotherapy atezolizumab (Tecentriq)

ASCO: Immunotherapy Beneficial in Advanced Bladder Cancer

0
About a quarter of older patients deemed too frail for chemo responded to atezolizumab
A new blood-based "liquid biopsy" could be a groundbreaking alternative to the traditional biopsy

ASCO: ‘Liquid Biopsy’ Shows Promise for Tumor Surveillance

0
Guardant360 predicts cancer DNA mutations and could help tailor treatments to avoid drug resistance